Further, overactivity of the endocannabinoid system perpetuates the problems associated with obesity (62) and drugs targeting CB1 have been used therapeutically to manage obesity but withdrawn due to CNS side effects (66). The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.